MTAP

Gianluca Mauri1,2,3, Giorgio Patelli4,2,3, Laura Roazzi2,3

  • 1IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy gianluca.mauri@unimi.it.

PubMed
概括

甲基氨酸酸化酶 (MTAP) 损失发生在5-10%的胃肠癌中,主要发生在上部胃肠道类型中. 这种MTAP损失不会使患者的预后恶化,并且通常与CDKN2A/B损失有关.